Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert-Jan Creemers

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 2, 2022
Quality of life and quality of care as experienced by patients with advanced cancer and their relatives: A multicentre observational cohort study (eQuiPe)Janneke van Roij, Natasja Raijmakers, Laurien Ham, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
Phase I study of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin for patients with gastric peritoneal metastasesNiels A D Guchelaar, Marion W Tops-Welten, Pieter C van der Sluis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 30, 2021
Implementation of a regional video multidisciplinary team meeting is associated with an improved prognosis for patients with oesophageal cancer A mixed methods approachJosianne C H B M Luijten, Vera C Haagsman, Misha D P Luyer, et al.
Psycho-Oncology|October 26, 2023
Trajectories of emotional functioning and experienced care of relatives in the last year of life of patients with advanced cancer: A longitudinal analysis of the eQuiPe studyLaurien Ham, Heidi P Fransen, Natasja J H Raijmakers, et al.
Acta Oncologica (Stockholm, Sweden)|October 28, 2023
Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trialSimone Augustinus, Thijmen Broekman, Geert-Jan Creemers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 29, 2024
Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based StudyNiels A D Guchelaar, Bo J Noordman, Marion W Welten, et al.
Frontiers in Oncology|April 11, 2022
Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide StudyEsther N Pijnappel, Melinda Schuurman, Anna D Wagner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2022
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patientsEmma C Hulshof, Mirjam de With, Femke M de Man, et al.
Cancers|March 6, 2021
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOXCharlotte I Stroes, Sandor Schokker, Remco J Molenaar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Relationship Between Quality of Life and Survival in Patients With Pancreatic and Periampullary Cancer: A Multicenter Cohort AnalysisTara M Mackay, Anouk E J Latenstein, Mirjam A G Sprangers, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|March 2, 2022
Quality of life and quality of care as experienced by patients with advanced cancer and their relatives: A multicentre observational cohort study (eQuiPe)Janneke van Roij, Natasja Raijmakers, Laurien Ham, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
Phase I study of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin for patients with gastric peritoneal metastasesNiels A D Guchelaar, Marion W Tops-Welten, Pieter C van der Sluis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 30, 2021
Implementation of a regional video multidisciplinary team meeting is associated with an improved prognosis for patients with oesophageal cancer A mixed methods approachJosianne C H B M Luijten, Vera C Haagsman, Misha D P Luyer, et al.
Psycho-Oncology|October 26, 2023
Trajectories of emotional functioning and experienced care of relatives in the last year of life of patients with advanced cancer: A longitudinal analysis of the eQuiPe studyLaurien Ham, Heidi P Fransen, Natasja J H Raijmakers, et al.
Acta Oncologica (Stockholm, Sweden)|October 28, 2023
Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trialSimone Augustinus, Thijmen Broekman, Geert-Jan Creemers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 29, 2024
Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based StudyNiels A D Guchelaar, Bo J Noordman, Marion W Welten, et al.
Frontiers in Oncology|April 11, 2022
Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide StudyEsther N Pijnappel, Melinda Schuurman, Anna D Wagner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2022
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patientsEmma C Hulshof, Mirjam de With, Femke M de Man, et al.
Cancers|March 6, 2021
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOXCharlotte I Stroes, Sandor Schokker, Remco J Molenaar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Relationship Between Quality of Life and Survival in Patients With Pancreatic and Periampullary Cancer: A Multicenter Cohort AnalysisTara M Mackay, Anouk E J Latenstein, Mirjam A G Sprangers, et al.
Pageof 10